Treatment strategies for pediatric nodular lymphocyte predominant Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 47, Issue 8, 2006, Pages 1450-1451

  Vassilakopoulos, Theodoros P ^a   Angelopoulou, Maria K ^a   Pangalis, Gerassimos A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CD15 ANTIGEN; CD20 ANTIBODY; CD20 ANTIGEN; CD30 ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; HUMAN; IMMUNOPHENOTYPING; INFERTILITY; MYELODYSPLASTIC SYNDROME; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NOTE; PEDIATRICS; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR REGRESSION; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; HODGKIN DISEASE; HUMANS; LYMPHOCYTES; TREATMENT OUTCOME;

EID: 33748557471     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600709507     Document Type: Note

References (9)

1. Schwartz, C. (2005) Special issues in pediatric Hodgkin's disease Eur J Haematol, 75, pp. 55-62.
2. van Grotel, M and Lam, K and de Man, R and Beishuizen, A and Pieters, R and van den Heuvel-Eibrink, M. (2006) High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only Leuk Lymphoma, 47, pp. 1504-1510.
3. Vassilakopoulos, T and Angelopoulou, M and Siakantaris, M and Kontopidou, F and Dimopoulou, M and Kokoris, S and (2004) Combination chemotherapy plus low-dose involved field radiotherapy for early clinical stage Hodgkin's lymphoma Int J Radiat Oncol Biol Phys, 59, pp. 765-781.
4. Nachman, J and Sposto, R and Herzog, P and Gilchrist, G and Wolden, S and Thomson, J and (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol, 20, pp. 3765-3771.
5. Klimm, B and Schnell, R and Diehl, V and Engert, A. (2005) Current treatment and immunotherapy of Hodgkin's lymphoma Haematologica, 90, pp. 1680-1692.
6. Nogova, L and Reineke, T and Eich, H and Josting, A and Muller-Hermelink, H and Wingbermuhle, K and (2005) Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin Study Group (GHSG) Ann Oncol, 16, pp. 1683-1687.
7. Straus, D and Portlock, C and Qin, J and Myers, J and Zelenetz, A and Moskowitz, C and (2004) Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) followed by radiation therapy (RT) vs. ABVD alone for stages I, II and IIIA non bulky Hodgkin's disease Blood, 104, pp. 3483-3489.
8. Meyer, R and Gospodarowicz, M and Connors, J and Pearcey, R and Bezjak, A and Wells, W and (2005) Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group J Clin Oncol, 23, pp. 4634-4642.
9. Pellegrino, B and Terrier-Lacombe, M and Oberlin, O and Leblanc, T and Perel, Y and Bertrand, Y and (2003) Lymphocyte-predominant Hodgkin's lymphoma in children: Therapeutic abstention after initial lymph node resection - a study of the French Society of Pediatric Oncology J Clin Oncol, 21, pp. 2948-2952.